nPOD is pleased to welcome 10 new investigators. nPOD now supports nearly 50 investigators all over the world that are invested in type 1 diabetes research. These investigators will use nPOD tissues to better understand T1D and what causes it in the hopes of finding a cure. Below is a list of recently approved projects:

Project Name: Generation of pluripotent stem cells from diabetics
PI: Dieter Egli, Ph.D.,Columbia University
Co-PI: Rudy Leibel, M.D.,Columbia University
Co-PI: Scott Noggle, Ph.D.,Columbia University

Project Name: Reconstruction of HHLS mice with bone marrow from patients with T1DM
PI: Kevan Herold, M.D.,Yale University
Co-PI: Alfred Bothwell, Ph.D.,Yale University

Project Name: Investigating the de-differentiated state of the ß-cell in human diabetic patient tissues
PI: Matthias Hebrok, Ph.D.,University of California, San Francisco

Project Name: Vascular endothelial growth factor receptor signaling regulates the pathogenesis of diabetes mellitus type 1
PI: Jeffrey Bluestone, Ph.D.,University of California, San Francisco
Co-PI: Armando Villalta, Ph.D.,University of California, San Francisco

Project Name: Characterization of beta cell ER stress markers in type 1 diabetes
PI: Decio Eizirik, M.D., Ph.D.,Universitè Libre de Bruxelles
Co-PI: Ihsane Marhfour, Ph.D.,Universitè Libre de Bruxelles